Cancer researcher Dr. Brian Druker and two colleagues were named recipients in Tokyo Wednesday of the 2012 Japan Prize for their work in developing the leukemia drug Imatinib, marketed as Gleevec.
http://www.bizjournals.com/portland/news/2012/01/24/brian-druker-wins-prestigious-japan.html